Jupiter Neurosciences
JUNS | NASDAQ
$1.70
-$0.06 (-3.41%)
At close: Nov 16, 2026, 4:00 PM ET
$1.70
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.41%
(1D)No price chart data available for 1D timeframe.
Rating
31.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #750/1021 (Top 73%)
Key Statistics
Market Data
Market Cap $2.24M
1D Range
1.63 1.82
52W Range
1.63 97.50
Valuation (TTM)
PE -0.09
PB -6.12
EV/EBITDA -0.27
Valuation (NTM)
Forward PE 0.39
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -323.4%
SBC Adj. FCF Yield -328.2%
SBC Impact -1.5%
Margins
Gross Margin 88.3%
Operating Margin -15166.7%
FCF Margin -11206.0%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
-42.5%
Dil EPS 3Y | 5Y -47.0% |
15.9%
FCF 3Y | 5Y -75.7% |
-54.0%
Returns
ROA -247.4%
ROE 747.3%
ROIC -709.4%
Financial Health
Net Debt
$227.2K
Current Ratio 0.66
Interest Coverage -47.42
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main object...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Dec 3, 2024
Website jupiterneurosciences.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove JUNS